Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Cottu

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Bulletin Du Cancer|December 18, 2015
[New options in adjuvant endocrine therapy in breast cancer]Aurélien Saltel-Fulero, Anne Donnadieu, Solenne Leman-Detours, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2026
Reducing waiting time of injectable anticancer drug preparations in day care oncology units: A summary of evidence, implemented strategies, and perspectives for hospital pharmacistsJean-Stéphane Giraud, Mélanie Brun, Romain Desmaris, et al.
International Journal of Cancer|June 29, 2023
Outcomes and toxicity of concurrent CDK4/6 inhibitor and locoregional radiotherapy for patients with de novo metastatic breast cancerArnaud Beddok, Victoire Mouren, Paul Cottu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2008
Progressive inflammatory breast cancer in patient receiving chemotherapy: the importance of radiotherapy as a part of locoregional treatmentCyrus Chargari, Youlia M Kirova, Paul Cottu, et al.
Breast (Edinburgh, Scotland)|December 27, 2021
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-makingPaul Cottu, Scott David Ramsey, Oriol Solà-Morales, et al.
Bulletin Du Cancer|June 22, 2021
[Targeting the cyclin-dependent kinases 4/6 in advanced breast cancers]Florence Coussy, Elise Deluche, Barbara Pistilli, et al.
Soins; La Revue De Reference Infirmiere|August 9, 2012
[Breast cancer and the hand-foot syndrome]Claire Llambrich, Marie-Christine Falcou, Yann De Rycke, et al.
International Journal of Clinical Pharmacy|March 4, 2011
Dose standardisation of anticancer drugsAnne-Lise Pouliquen, Laurence Escalup, Nathalie Jourdan, et al.
Journal of Clinical Laboratory Analysis|January 21, 2010
Lectin affinity electrophoresis of serum alkaline phosphatase in metastasized breast cancerThierry Le Bricon, Cécile Gay-Bellile, Paul Cottu, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 15, 2023
Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centreMathilde Dupre, Laurence Escalup, Sandy Blondeel-Gomes, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Bulletin Du Cancer|December 18, 2015
[New options in adjuvant endocrine therapy in breast cancer]Aurélien Saltel-Fulero, Anne Donnadieu, Solenne Leman-Detours, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 18, 2026
Reducing waiting time of injectable anticancer drug preparations in day care oncology units: A summary of evidence, implemented strategies, and perspectives for hospital pharmacistsJean-Stéphane Giraud, Mélanie Brun, Romain Desmaris, et al.
International Journal of Cancer|June 29, 2023
Outcomes and toxicity of concurrent CDK4/6 inhibitor and locoregional radiotherapy for patients with de novo metastatic breast cancerArnaud Beddok, Victoire Mouren, Paul Cottu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 6, 2008
Progressive inflammatory breast cancer in patient receiving chemotherapy: the importance of radiotherapy as a part of locoregional treatmentCyrus Chargari, Youlia M Kirova, Paul Cottu, et al.
Breast (Edinburgh, Scotland)|December 27, 2021
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-makingPaul Cottu, Scott David Ramsey, Oriol Solà-Morales, et al.
Bulletin Du Cancer|June 22, 2021
[Targeting the cyclin-dependent kinases 4/6 in advanced breast cancers]Florence Coussy, Elise Deluche, Barbara Pistilli, et al.
Soins; La Revue De Reference Infirmiere|August 9, 2012
[Breast cancer and the hand-foot syndrome]Claire Llambrich, Marie-Christine Falcou, Yann De Rycke, et al.
International Journal of Clinical Pharmacy|March 4, 2011
Dose standardisation of anticancer drugsAnne-Lise Pouliquen, Laurence Escalup, Nathalie Jourdan, et al.
Journal of Clinical Laboratory Analysis|January 21, 2010
Lectin affinity electrophoresis of serum alkaline phosphatase in metastasized breast cancerThierry Le Bricon, Cécile Gay-Bellile, Paul Cottu, et al.
European Journal of Hospital Pharmacy : Science and Practice|May 15, 2023
Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centreMathilde Dupre, Laurence Escalup, Sandy Blondeel-Gomes, et al.
Pageof 14